2014
Current drug use and lack of HIV virologic suppression: point-of-care urine drug screen versus self-report
Qian HZ, Mitchell VJ, Bebawy S, Cassell H, Perez G, McGowan CC, Sterling TR, Vermund SH, D’Aquila R, Hulgan T. Current drug use and lack of HIV virologic suppression: point-of-care urine drug screen versus self-report. BMC Infectious Diseases 2014, 14: 508. PMID: 25234368, PMCID: PMC4175271, DOI: 10.1186/1471-2334-14-508.Peer-Reviewed Original ResearchConceptsUrine drug screensCurrent drug usePositive urine drug screenComputer Assisted Self-InterviewVirologic suppressionDrug useAntiretroviral therapyDrug screensNegative urine drug screensHigher CD4 countsHIV disease progressionRoutine clinic visitsHIV virologic suppressionCross-sectional studyLower self-reported ratesSelf-reported ratesCD4 countClinic visitsPrognostic informationDisease progressionCaucasian raceART usersLower likelihoodResultsAbout halfSelf interview
2007
A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus
Stringer EM, Kaseba C, Levy J, Sinkala M, Goldenberg RL, H. B, Matongo I, Vermund SH, Mwanahamuntu M, Stringer JS. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. American Journal Of Obstetrics And Gynecology 2007, 197: 144.e1-144.e8. PMID: 17689627, PMCID: PMC2730754, DOI: 10.1016/j.ajog.2007.03.031.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusIntrauterine contraceptive devicePelvic inflammatory diseaseHormonal contraceptionImmunodeficiency virusInflammatory diseasesDisease progressionContraceptive deviceRapid HIV disease progressionHIV disease progressionClinical disease progressionUrgent further studyCopper intrauterine contraceptive deviceContraceptionWomenFurther studiesDiseaseProgressionVirusPostpartumTrials
1998
Serum Retinol and HIV-1 RNA Viral Load in Rapid and Slow Progressors
Camp W, Allen S, Alvarez J, Jolly P, Weiss H, Phillips J, Karita E, Serufilira A, Vermund S. Serum Retinol and HIV-1 RNA Viral Load in Rapid and Slow Progressors. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: 401-406. PMID: 9704954, DOI: 10.1097/00042560-199808010-00022.Peer-Reviewed Original ResearchConceptsSerum retinol levelsHIV-1 RNA viral loadLow viral loadLow serum retinol levelsRNA viral loadSlow progressorsRetinol levelsViral loadHIV serologySerum retinolDisease progressionFirst HIV-positive testHigher serum retinol levelsAsymptomatic HIV infectionHigh HIV loadLow serum retinolSerum retinol valuesHIV disease progressionHIV-positive testHigh viral loadThirty HIVHIV loadHIV infectionRapid progressorsSerum vitaminSerum Retinol and HIV-1 RNA Viral Load in Rapid and Slow Progressors
Camp W, Allen S, Alvarez J, Jolly P, Weiss H, Phillips J, Karita E, Serufilira A, Vermund S. Serum Retinol and HIV-1 RNA Viral Load in Rapid and Slow Progressors. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: 21-26. PMID: 9593454, DOI: 10.1097/00042560-199805010-00004.Peer-Reviewed Original ResearchConceptsSerum retinol levelsLow viral loadHIV-1 RNA viral loadLow serum retinol levelsRNA viral loadSlow progressorsRetinol levelsViral loadHIV serologySerum retinolDisease progressionFirst HIV-positive testHigher serum retinol levelsAsymptomatic HIV infectionHigh HIV loadLow serum retinolSerum retinol valuesHIV disease progressionHIV-positive testHigh viral loadThirty HIVHIV loadHIV infectionRapid progressorsSerum vitamin